Keywords: HIV-infection, chronic kidney disease, tubulo-interstitial lesion, glomerular lesion of kidneys


Introduction. HIV prevalence is one of the most important issues of contemporary medicine. Over a 30-year history of this disease more than 75 million people have been infected with HIV, nearly 30 million adults and children of died. In the future decades, its significance in world premature mortality rates continues to rise. The objective of the study was to establish clinical and laboratory features of kidney lesions in HIV infection.

Methods. The study involved 292 HIV-infected patients, who were managed outpatiently at the Chernivtsi Regional AIDS Center. Taking into account the main markers of kidney lesions: persistent proteinuria and glomerular filtration rate <60 mL/min/1.73 m2, 48 persons were diagnosed with chronic kidney disease (CKD), which was very frequently accompanied by dysfunction of these organs.

Results. Increasing proteinuria rate is accompanied by a significant renal dysfunction and more frequently is combined with arterial hypertension as well as hematuria without significant differences in the incidence of opportunistic diseases. The mean reciprocal correlation between the levels of proteinuria and glomerular filtration rate (r=-0.562, p<0.01), as well as between the levels of proteinuria and hemoglobin (r=-0.596, p<0.01) have been established as well.

Conclusions. Kidney lesions in HIV-infected are most often characterized by tubulointerstitial lesions. At the same time, glomerular kidney lesion, which is much less common, is accompanied by a significantly higher level of HIV RNA.


1. Alfvén T, Erkkola T, Ghys PD, Padayachy J, Warner-Smith M, Rugg D, De Lay P. Global AIDS Reporting-2001 to 2015: Lessons for monitoring the sustainable development goals. AIDS and Behavior. 2017 Jul 1;21(1):5-14.

2. Piot P, Karim SS, Hecht R, Legido-Quigley H, Buse K, Stover J, Resch S, Ryckman T, Møgedal S, Dybul M, Goosby E. Defeating AIDS—advancing global health. The Lancet. 2015 Jul 11;386(9989):171-218.

3. Pokrovsky VV, Yurin OG, Kravchenko AV, Belyaeva VV, Ermak TN, Canestri VG, Shahgildyan VI, Kozyrin NV, Buravtsova VV, Narsia RS, Pokrovskaya AV. National recommendations for follow-up and treatment of patients with HIV infection. Clinical protocol. Epidemiology and infectious diseases. 2015 (6): 14. [In Russian].

4. Campos P, Ortiz A, Soto K. HIV and kidney diseases: 35 years of history and consequences. Clinical kidney journal. 2016 Oct 25:772-81.

5. Shylov EM, editor. Nephrology: guideline for postgraduate education. Moscow: Geotar Media; 2008, 696 p. [In Russian].

6. Woo KT, Chan CM. KDIGO clinical practice guidelines for bisphosphonate treatment in chronic kidney disease. Kidney international. 2011 Sep 1;80(5):553-4.

7. Fine DM, Perazella MA, Lucas GM, Atta MG. Renal disease in patients with HIV infection. Drugs. 2008 May 1;68(7):963-80.

8. Winston J, Deray G, Hawkins T, Szczech L, Wyatt C, Young B, Mayer KH. Kidney disease in patients with HIV infection and AIDS. Clinical Infectious Diseases. 2008 Dec 1;47(11):1449-57. doi: 10.1086/593099

9. Tada M, Masumoto S, Hinoshita F. Clinical remission of IgA nephropathy in an HIV-positive patient after combined treatment with tonsillectomy and steroid pulse therapy. CEN case reports. 2015 Nov 1;4(2):157-61.

10. Wearne N, Swanepoel CR, Boulle A, Duffield MS, Rayner BL. The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations. Nephrology Dialysis Transplantation. 2011 Dec 26;27(11):4109-18.
How to Cite
AndrushchakМ. О. (2019). KIDNEY LESIONS IN HIV-INFECTED PATIENTS. International Journal of Medicine and Medical Research, 4(2), 5-12.